Spiriva capsules contain 18 mcg of tiotropium and are light green ... other than inhaled anticholinergics. The coprimary endpoints were the proportion of patients with COPD exacerbation and ...

Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions under Part D or Medicare Advantage (Part C) plans. With Medicare coverage, you may still have ...

AstraZeneca recently announced the completion of clinical studies for a next-generation propellant (NGP) version of its chronic obstructive pulmonary ... development of green inhalers is a ...

Medicare Part D and Medicare Advantage (Part C) plans with drug coverage typically cover inhalers for COPD. But you may still be responsible for a portion of the cost. If you have chronic ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary disorder ... in what it calls ‘green prescribing.’ ...